Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Finished Goods (2016 - 2025)

Collegium Pharmaceutical has reported Finished Goods over the past 10 years, most recently at $20.2 million for Q3 2025.

  • Quarterly results put Finished Goods at $20.2 million for Q3 2025, up 23.13% from a year ago — trailing twelve months through Sep 2025 was $20.2 million (up 23.13% YoY), and the annual figure for FY2024 was $17.8 million, up 17.12%.
  • Finished Goods for Q3 2025 was $20.2 million at Collegium Pharmaceutical, roughly flat from $20.2 million in the prior quarter.
  • Over the last five years, Finished Goods for COLL hit a ceiling of $36.9 million in Q1 2022 and a floor of $9.5 million in Q2 2021.
  • Median Finished Goods over the past 5 years was $15.2 million (2023), compared with a mean of $16.5 million.
  • Biggest five-year swings in Finished Goods: surged 280.78% in 2022 and later tumbled 62.81% in 2023.
  • Collegium Pharmaceutical's Finished Goods stood at $12.7 million in 2021, then grew by 27.77% to $16.2 million in 2022, then fell by 6.29% to $15.2 million in 2023, then increased by 17.12% to $17.8 million in 2024, then rose by 13.64% to $20.2 million in 2025.
  • The last three reported values for Finished Goods were $20.2 million (Q3 2025), $20.2 million (Q2 2025), and $18.5 million (Q1 2025) per Business Quant data.